Funding Rounds
ADmit Therapeutics

ADmit Therapeutics Series A (2023, $5M)

ADmit Therapeutics

Early detection of Alzheimer's disease (AD) technology.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $5.80M

Investors